Drug intelligence / Profile preview

Ampicillin + Gentamicin + Zinc

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous
01

Overview

The combination of ampicillin and gentamicin is a well-documented synergistic antibiotic therapy, primarily used for treating various bacterial infections such as pediatric sepsis and obstructive pyelonephritis. Ampicillin is a semi-synthetic penicillin derivative that functions as a broad-spectrum antibiotic by inhibiting bacterial cell wall synthesis. Gentamicin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis, primarily effective against gram-negative organisms. The synergistic effect of ampicillin and gentamicin makes them more effective together than individually, leading to high survival rates in pediatric sepsis (96%) and effective sterilization of infected kidneys in obstructive pyelonephritis. While zinc is known for its immune-modulating properties and is sometimes used as a supplement in infectious disease management, its specific combination with ampicillin and gentamicin is not directly mentioned in the provided search results.

02

Targets

30S A-site (Bacterial ribosomal 30S A-site)PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Ampicillin + Gentamicin + Zinc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ampicillin + Gentamicin + Zinc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call